Literature DB >> 32950473

Endoplasmic reticulum stress related factor IRE1α regulates TXNIP/NLRP3-mediated pyroptosis in diabetic nephropathy.

Ruiqiong Ke1, Yan Wang1, Shihua Hong1, Lixia Xiao2.   

Abstract

The nod-like receptor protein-3 (NLRP3)-mediated pyroptosis is involved in kidney diseases. Thioredoxin interacting protein (TXNIP) directly interacts with NLRP3. This study aimed to probe the mechanism of TXNIP and NLRP3 pathway in diabetic nephropathy (DN). Marker detection and histological staining indicated that in DN rats, the renal function was destroyed, and the TXNIP/NLRP3 axis was activated to induce inflammatory generation and pyroptosis. The protein levels of TXNIP, NLRP3 inflammatory components and endoplasmic reticulum stress (ERS)-related factors (ATF4, CHOP and IRE1α) were measured. DN rats were injected with LV-TXNIP-shRNA or IRE1α RNase specific inhibitor (STF-083010) to examine ERS- and pyroptosis-related proteins, and renal injury. Silencing TXNIP inhibited the NLRP3 axis and reduced renal damage in DN rats. ERS was activated in DN rats, and miR-200a expression was degraded by IRE1α. miR-200a bound to TXNIP. NRK-52E cells were induced by high glucose (HG) to simulate DN in vitro. The damage and pyroptosis of NRK-52E cells were analyzed. After inhibiting IRE1α, miR-200a expression increased and TXNIP expression decreased. miR-200a inhibition in HG-induced NRK-52E cells partially reversed the reduced pyroptosis by STF-083010. Overall, IRE1α upregulates miR-200a degradation in DN rats, and stimulates the TXINP/NLRP3 pathway-mediated pyroptosis and renal damage.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diabetic nephropathy; Endoplasmic reticulum stress; IRE1α; NLRP3; Pyroptosis; TXINP; microRNA-200a

Year:  2020        PMID: 32950473     DOI: 10.1016/j.yexcr.2020.112293

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  12 in total

1.  Intermedin1-53 Inhibits NLRP3 Inflammasome Activation by Targeting IRE1α in Cardiac Fibrosis.

Authors:  Lin-Shuang Zhang; Jin-Sheng Zhang; Yue-Long Hou; Wei-Wei Lu; Xian-Qiang Ni; Fan Lin; Xiu-Ying Liu; Xiu-Jie Wang; Yan-Rong Yu; Mo-Zhi Jia; Chao-Shu Tang; Ling Han; San-Bao Chai; Yong-Fen Qi
Journal:  Inflammation       Date:  2022-02-17       Impact factor: 4.092

Review 2.  The Role of the NLRP3 Inflammasome in Mediating Glomerular and Tubular Injury in Diabetic Nephropathy.

Authors:  B M Williams; C L Cliff; K Lee; P E Squires; C E Hills
Journal:  Front Physiol       Date:  2022-06-09       Impact factor: 4.755

Review 3.  The Role of the Effects of Endoplasmic Reticulum Stress on NLRP3 Inflammasome in Diabetes.

Authors:  Shuangyu Lv; Xiaotian Li; Honggang Wang
Journal:  Front Cell Dev Biol       Date:  2021-04-14

4.  Atorvastatin Regulates MALAT1/miR-200c/NRF2 Activity to Protect Against Podocyte Pyroptosis Induced by High Glucose.

Authors:  Yi Zuo; Li Chen; Xiaoyun He; Zhen Ye; Ling Li; Zhanhong Liu; Suxian Zhou
Journal:  Diabetes Metab Syndr Obes       Date:  2021-04-13       Impact factor: 3.168

5.  Inhibition of the PERK/TXNIP/NLRP3 Axis by Baicalin Reduces NLRP3 Inflammasome-Mediated Pyroptosis in Macrophages Infected with Mycobacterium tuberculosis.

Authors:  Yan Fu; Jingjing Shen; Yinhong Li; Fanglin Liu; Bangzuo Ning; Yuejuan Zheng; Xin Jiang
Journal:  Mediators Inflamm       Date:  2021-11-08       Impact factor: 4.711

Review 6.  Endoplasmic Reticulum Stress of Gut Enterocyte and Intestinal Diseases.

Authors:  Han Gao; Chengwei He; Rongxuan Hua; Yuexin Guo; Boya Wang; Chen Liang; Lei Gao; Hongwei Shang; Jing-Dong Xu
Journal:  Front Mol Biosci       Date:  2022-03-24

Review 7.  NLRP3 Inflammasome in Metabolic-Associated Kidney Diseases: An Update.

Authors:  Wei Xiong; Xian-Fang Meng; Chun Zhang
Journal:  Front Immunol       Date:  2021-07-08       Impact factor: 7.561

Review 8.  Role of Thioredoxin-Interacting Protein in Diseases and Its Therapeutic Outlook.

Authors:  Naila Qayyum; Muhammad Haseeb; Moon Suk Kim; Sangdun Choi
Journal:  Int J Mol Sci       Date:  2021-03-09       Impact factor: 5.923

Review 9.  Role of Pyroptosis in Diabetes and Its Therapeutic Implications.

Authors:  Abdullah Al Mamun; Yanqing Wu; Fatema Nasrin; Afroza Akter; Masuma Afrin Taniya; Fahad Munir; Chang Jia; Jian Xiao
Journal:  J Inflamm Res       Date:  2021-05-24

Review 10.  GSDMD-mediated pyroptosis: a critical mechanism of diabetic nephropathy.

Authors:  Yi Zuo; Li Chen; Huiping Gu; Xiaoyun He; Zhen Ye; Zhao Wang; Qixiang Shao; Caiping Xue
Journal:  Expert Rev Mol Med       Date:  2021-12-27       Impact factor: 5.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.